EMPLOYEE BENEFIT AND EQUITY PLANS |
(13)EMPLOYEE BENEFIT AND EQUITY PLANS
We have two active equity-based stock plans. Under these plans, incentive and nonqualified options, SARs and annual cash incentive awards may be issued to directors and employees pursuant to decisions of the Compensation Committee, which is made up of non-employee, independent directors from the Board of Directors. All awards granted have been issued at prevailing market prices at the time of the grant. Since the middle of 2005, only SARs have been granted under the plans to limit the dilutive impact of our equity plans. Information with respect to stock option and SARs activities is summarized below:
Weighted Average
Exercise
Shares Price
Outstanding on December31, 2008 7,248,666 $ 26.15
Granted 1,705,429 36.85
Exercised (1,287,291 ) 13.44
Expired/forfeited (61,548 ) 40.08
Outstanding on September30, 2009 7,605,256 $ 30.58
The following table shows information with respect to outstanding stock options and SARs at September30, 2009:
Outstanding Exercisable
Weighted- Weighted- Weighted-
Average Average Average
Remaining Exercise Exercise
Range of Exercise Prices Shares Contractual Life Price Shares Price
$1.29$9.99 933,036 2.18 $ 3.39 933,036 $ 3.39
10.0019.99 1,390,634 0.65 16.79 1,390,634 16.79
20.0029.99 1,150,961 1.48 24.30 1,140,261 24.28
30.0039.99 2,424,333 3.34 34.14 767,380 34.42
40.0049.99 619,437 4.59 41.73 55,485 41.69
50.0059.99 713,440 3.39 58.49 214,387 58.57
60.0069.99 26,677 3.63 65.40 8,529 65.33
70.0075.00 346,738 3.64 75.00 122,563 75.00
Total 7,605,256 2.54 $ 30.58 4,632,275 $ 22.72
The weighted average fair value of an option/SAR to purchase one share of common stock granted during 2009 was $15.41. The fair value of each stock option/SAR granted during 2009 was estimated as of the date of grant using the Black-Scholes-Merton option-pricing model based on the following average assumptions: risk-free interest rate of 1.5%; dividend yield of 0.4%; expected volatility of 59%; and an expected life of 3.5years.
As of September30, 2009, the aggregate intrinsic value (the difference in value between exercise and market price) of the awards outstanding was $158.6million. The aggregate intrinsic value and weighted average remaining contractual life of stock option awards currently exercisable was $128.7million and 1.7years. As of September30, 2009, the number of fully vested awards and awards expected to vest was 7.5million. The weighted average exercise price and weighted average remaining contractual life of these awards was $30.35 and 2.5years and the aggregate intrinsic value was |